Showing items 1–100
Method of treating cancer by administering immune effector cells expressing a chimeric…
Grant US-11872249-B2
United States of America
Compositions and methods for TCR reprogramming using fusion proteins
Grant US-11851491-B2
United States of America
Reducing levels of nicotinic alkaloids in plants
Grant US-11839231-B2
United States of America
Antibody molecules to PD-1 and uses thereof
Grant US-11827704-B2
United States of America
Treatment of LAG-3 positive tumors
Grant US-11807686-B2
United States of America
DLL3 binding proteins and methods of use
Grant US-11807692-B2
United States of America
Oncolytic virus for expression of immune checkpoint modulators
Grant US-11779619-B2
United States of America
Vista antagonist and methods of use
Grant US-11752189-B2
United States of America
Methods for targeting the immune checkpoint PD1 pathway for treating pulmonary fibrosis
Grant US-11725056-B2
United States of America
Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1…
Grant US-11723975-B2
United States of America
CD137 antibodies and PD-1 antagonists and uses thereof
Grant US-11718679-B2
United States of America
Methods for treating hematologic cancers
Grant US-11708412-B2
United States of America
Antiviral pyrazolopyridinone compounds
Grant US-11667613-B2
United States of America
Anti-CD39 antibody compositions and methods
Grant US-11655303-B2
United States of America
Anti-human vista antibodies and use thereof
Grant US-11649283-B2
United States of America
Single chain variable fragment CD3 binding proteins
Grant US-11623958-B2
United States of America
Mesothelin binding proteins
Grant US-11607453-B2
United States of America
Anti-human vista antibodies and use thereof
Grant US-11603403-B2
United States of America
Anti-human vista antibodies and use thereof
Grant US-11603402-B2
United States of America
Approach for treatment of cancer via immunomodulation by using talabostat
Grant US-11564986-B2
United States of America
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
Grant US-11534431-B2
United States of America
Inducible monovalent antigen binding protein
Grant US-11535668-B2
United States of America
Vista modulators for diagnosis and treatment of cancer
Grant US-11529416-B2
United States of America
Anti-human VISTA antibodies and use thereof
Grant US-11525000-B2
United States of America
Targeting DNA-PKCS and B7-H1 to treat cancer
Grant US-11504376-B2
United States of America
Single domain serum albumin binding protein
Grant US-11453716-B2
United States of America
Monoclonal antibodies to programmed death 1 (PD-1)
Grant US-11414487-B2
United States of America
Pro-inflammatory and adjuvant functions of toll-like receptor 4 antagonists
Grant US-11400153-B2
United States of America
Compositions and methods for TCR reprogramming using fusion proteins
Grant US-11377638-B2
United States of America
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof
Grant US-11365255-B2
United States of America
CD229 CAR T cells and methods of use thereof
Grant US-11365252-B2
United States of America
Methods and compositions for the treatment of persistent infections and cancer by…
Grant US-11359013-B2
United States of America
Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists
Grant US-11351250-B2
United States of America
Combination therapies
Grant US-11344620-B2
United States of America
Anti-PD-1 antibodies and methods of use thereof
Grant US-11345755-B2
United States of America
Anti-IL-27 antibodies and uses thereof
Grant US-11332524-B2
United States of America
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
Grant US-11306143-B2
United States of America
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
Grant US-11274152-B2
United States of America
Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof
Grant US-11254746-B2
United States of America
Compositions and methods for TCR reprogramming using fusion proteins
Grant US-11242376-B2
United States of America
Anti-vista antibodies and fragments
Grant US-11242392-B2
United States of America
Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals
Grant US-11234977-B2
United States of America
FLT3 binding proteins and methods of use
Grant US-11180563-B2
United States of America
Vista modulators for diagnosis and treatment of cancer
Grant US-11180557-B2
United States of America
Method of detecting TIM-3 using antibody molecules to TIM-3
Grant US-11155620-B2
United States of America
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen…
Grant US-11149076-B2
United States of America
Trispecific proteins and methods of use
Grant US-11136403-B2
United States of America
Methods for treating cancer in patients with elevated levels of Bim
Grant US-11136393-B2
United States of America
Use of vista agonists and antagonists to suppress or enhance humoral immunity
Grant US-11123426-B2
United States of America
COMBINATION THERAPY FOR CANCER COMPRISING PD-1 AXIS BINDING ANTAGONIST AND IL6 ANTAGONIST
Application WO-2021177980-A1
World Intellectual Property Organisation (WIPO)
Reducing levels of nicotine in plants
Grant US-11109617-B2
United States of America
Compositions and methods for TCR reprogramming using fusion proteins
Grant US-11085021-B2
United States of America
Antiviral pyridopyrazinedione compounds
Grant US-11072610-B2
United States of America
Multispecific binding constructs against checkpoint molecules and uses thereof
Grant US-11046769-B2
United States of America
Compositions and methods for TCR reprogramming using fusion proteins
Grant US-11028142-B2
United States of America
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding…
Grant US-11026976-B2
United States of America
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
Grant US-11014987-B2
United States of America
Anti-VISTA antibodies and fragments
Grant US-11009509-B2
United States of America
Anti-PD-L1 antibodies
Grant US-10981995-B2
United States of America
Antibody molecules to TIM-3 and uses thereof
Grant US-10981990-B2
United States of America
Anti-PD-1 antibodies and uses thereof
Grant US-10973915-B2
United States of America
Fused indazole pyridone compounds as antivirals
Grant US-10975078-B2
United States of America
Anti-PD-L1 antibodies
Grant US-10954302-B2
United States of America
Trispecific binding proteins and methods of use
Grant US-10954311-B2
United States of America
VISTA antagonist and methods of use
Grant US-10933115-B2
United States of America
Treatment of cancer using humanized anti-CD19 chimeric antigen receptor
Grant US-10927184-B2
United States of America
B cell maturation antigen binding proteins
Grant US-10927180-B2
United States of America
Method of identifying anti-VISTA antibodies
Grant US-10899836-B2
United States of America
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
Grant US-10894830-B2
United States of America
Antibodies to B7-H1
Grant US-10875923-B2
United States of America
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
Grant US-10864203-B2
United States of America
Prostate specific membrane antigen binding protein
Grant US-10849973-B2
United States of America
Treatment of cancer using a CD33 chimeric antigen receptor
Grant US-10851166-B2
United States of America
Antibody molecules to PD-L1 and methods of treating cancer
Grant US-10851165-B2
United States of America
PSMA targeting trispecific proteins and methods of use
Grant US-10844134-B2
United States of America
DLL3 binding proteins and methods of use
Grant US-10815311-B2
United States of America
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
Application EP-3721903-A1
European Patent Office
Antibodies that bind CD39 and uses thereof
Grant US-10793637-B2
United States of America
VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof
Grant US-10781254-B2
United States of America
Bacterial ghosts for the treatment of cancer
Grant US-10772944-B2
United States of America
Combination of oncolytic virus with immune checkpoint modulators
Grant US-10765710-B2
United States of America
Antibody molecules to PD-1 and uses thereof
Grant US-10752687-B2
United States of America
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
Grant US-10745467-B2
United States of America
Antibodies that bind CD39 and uses thereof
Grant US-10738128-B2
United States of America
MSLN targeting trispecific proteins and methods of use
Grant US-10730954-B2
United States of America
Anti-PD-L1 antibodies
Grant US-10696745-B2
United States of America
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Grant US-10604575-B2
United States of America
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Grant US-10584170-B2
United States of America
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Grant US-10577423-B2
United States of America
Methods for treating hematologic cancers
Grant US-10570204-B2
United States of America
Oncolytic virus for expression of immune checkpoint modulators
Grant US-10555981-B2
United States of America
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding…
Grant US-10525083-B2
United States of America
Targeting DNA-PKcs and B7-H1 to treat cancer
Grant US-10517875-B2
United States of America
Antibody molecules to TIM-3 and uses thereof
Grant US-10472419-B2
United States of America
Anti-PD-1 antibodies and methods of use thereof
Grant US-10450373-B2
United States of America
Monoclonal antibodies to programmed death 1 (PD-1)
Grant US-10441655-B2
United States of America
Compositions and methods for TCR reprogramming using fusion proteins
Grant US-10442849-B2
United States of America
Reducing levels of nicotinic alkaloids in plants
Grant US-10368573-B2
United States of America
Methods and compositions for the treatment of persistent infections and cancer by…
Grant US-10370446-B2
United States of America
Showing items 1–100